Inflammatory demyelination of nerve in Guillain-Barré syndrome is triggered in most patients by prior infection with one of a series of organisms, including Campylobacter jejuni. The resulting inflammatory cascade, involving T cells, macrophages, complement, and cytokines, disrupts physiologic function of the peripheral nerve in part by targeting Schwann cells, the multipotential glial cells that synthesize multilamellar, compacted myelin and secrete growth factors. In vitro evidence suggests that the Schwann cell may itself be able to modulate the cascade by serving as an antigen-presenting cell and by producing cytokines and other acute-phase reactants.
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Demyelination of Schwann cell internodes and blocking of axonal contact through increases in growth factors, including heregulin, a member of the Neu differentiation factors, and peripheral nerve conduction are the consequences of a cascade of immune events that underlie the monophasic subacute paralcAMP (reviewed in [3] ). Immature, premyelinating Schwann cells express p75 NGFr (a low-affinity receptor for nerve ysis of Guillain-Barré syndrome (GBS). It is suggested that a preceding infection triggers both cellular and humoral immune growth factor), N-CAM (neural cell adhesion molecule), and S-100b (a Ca expresses myelin-associated proteins, including the principal glycoprotein (P0), PMP-22, basic proteins (P1 and P2), the C. jejuni is reported to be associated with both the acute motor axonal and the demyelinating varieties of GBS [1] . This myelin-associated glycoprotein, and CNPase. This phenotype is negative for NGFr and N-CAM but continues to express Sreview is limited to mechanisms by which Schwann cells, the principle myelinating glial cells of peripheral nerves, may con100b and CR1 (complement receptor type 1), which binds activation fragments (C3b and C4b) of the complement castribute to the development of endoneurial inflammation and nerve damage. Most reports have focused on peripheral nerve cade. Contact of the myelin internode stimulates axonal neurofilament phosphorylation and segregation of ion channels in myelin (PNM) as the target of immune-mediated attack since histochemical and ultrastructural studies of peripheral nerve of the axolemma. Axolemmal Na / channels are limited to the nodes of Ranvier, whereas K / channels occur under the in-GBS patients demonstrated focal destruction of the myelin with preservation of the myelin-producing Schwann cell (reviewed ternode [4] . This segregation contributes to electrophysiologic characteristics of nerve, allowing saltatory conduction. Demyein [2]). The ability of the Schwann cell to resist cytolysis and potentially mediate endoneurial pathophysiology through the lination unmasks the internodal K / channels, decreasing the efficiency of conduction of the ion impulse, blocking the spread release of cytokines and acute-phase reactants is the subject of current interest.
of passive depolarization, and leading to failure of impulse propagation. Injury to and degeneration of the distal axon through either trauma or inflammation cause Schwann cells to Schwann Cell Phenotype Expression lose the myelinating phenotype and leads to myelin vesiculation and complement-dependent phagocytosis of myelin by Schwann cells differentiate from progenitors derived from neural ectoderm. Schwann cell phenotypes with diverse biomacrophages [5, 6] . After axonal degeneration, residual columns of Schwann logic functions express different sets of genes regulated by cells are proposed to express adhesion molecules (e.g., N-CAM) and bind growth factors to surface p75 NGFr, which provides pathways for the regrowth of motor and sensory fibers
Presented: Workshop on the Development of Guillain-Barré Syndrome fol- [7] . Schwann cells secrete trophic factors, such as nerve growth trophic factor, which contribute to axonal out-growth and initiate and augment inflammation by T lymphocytes preand other inflammatory mediators (e.g., the third component viously sensitized in the systemic circulation [13 -15] . MHC of complement, C3) and to potentially act as secondary antigenexpression by Schwann cells of class II and class I molecules presenting cells within the endoneurium (figure 1). The ability also bears direct relevance as to whether they can serve as of Schwann cells to produce the proinflammatory cytokine ILcytotoxic targets for Th1, CD4 / , or CD8 / autoreactive T lym1b has several implications for C3 production and antigen phocytes. There is no clear evidence of Schwann cell cytolysis presentation.
by T cells in GBS. Enhanced T cell proliferative responses in In vitro, Schwann cells constitutively express low levels of the circulation of GBS patients are directed against peptides C3 mRNA and protein, which can be increased significantly of P0 and P2 [16], both of which are expressed on peripheral in a delayed manner by agents that increase intracellular cAMP myelin and not on Schwann cells. Since a Schwann cell antigen and the cytokines interferon (IFN)-g, tumor necrosis factor
has not yet been defined and expression of Ia by human (TNF)-a, and IL-1b [8] . Induction of C3 mRNA and protein Schwann cells in vivo is still a matter of some debate [17] , the by dibutyryl (db)-cAMP requires new protein synthesis and is role of CD4 / T cells in mediating Schwann cell damage reinhibited by either a neutralizing anti -IL-1b antibody or an mains to be clarified. IL-1 receptor antagonist. This suggests that db-cAMP induces Peripheral nerve inflammatory infiltrates in both GBS and Schwann cells to synthesize IL-1b, which mediates C3 producexperimental allergic neuritis are principally Ia / macrophages, tion by Schwann cells in both an autocrine and paracrine fashthe primary effectors of demyelination. Macrophages interact ion through binding to a functional IL-1 receptor expressed on with opsonized targets through surface receptors for the Fc the Schwann cell surface. TGF-b also decreases db-cAMPportion of IgG, IgA, and complement activation fragments. induced C3 production by Schwann cells.
Interaction enhances the release of proteases capable of cleavMost complement proteins can be produced within the endoing structural myelin proteins and cytokines (TNF-a and ILneurium by resident and invading macrophages, fibroblasts, 1b), which may contribute to down-regulation of myelin gene and Schwann cells. Whether local production compares in any expression and stimulate Schwann cell proliferation [18] . Unway with the concentration of components in plasma or whether like the oligodendrocytes, TNF-a by itself does not cause they participate in any biologically meaningful way is not Schwann cell apoptosis [19] , but the combination of TNF-a known. Complement activation within the nervous system is in association with other cytokines, such as TGF-b, has not proposed to contribute to the pathophysiology of Alzheimer's disease and possibly to amyloid neuropathy, where C3d and been investigated.
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Complement as an Effector of Endoneurial Damage human and rat myelin membrane, an extension of Schwann cell plasma membrane, expressed only CD59 [25] . The lack The development of demyelination in GBS correlates with of C3 convertase regulation allows C3 fragments, C3b and the detection of C-fixing antibody against carbohydrate epiiC3b, to efficiently deposit on myelin membrane during antitopes of a variety of gangliosides and neural glycolipids, some body-mediated complement activation, and it likely contributes of which are expressed on the core sugars of C. jejuni lipopolyto activation of the alternative pathway of complement by PNM saccharide [20, 21] . In GBS patients, the presence of IgM antiin the absence of specific antibody [26] . Such distribution of PNM antibody and anti -Schwann cell antibody correlates with complement regulatory proteins could contribute to Schwann the clinical course and with the complement-activation prodcell survival while enhancing myelin opsonization and phagoucts in cerebrospinal fluid and serum (C3a, C5a, and sC5b-9) cytosis by macrophages through complement surface receptors and in peripheral nerve (C5b-9). Antibody to PNM can directly CR1 and CR3. mediate complement-dependent demyelination in vitro through Sublytic terminal complement complex insertion causes oliformation of channel-forming terminal complexes of complegodendrocytes to down-regulate myelin protein gene expresment, C5b-8 and C5b-9. These channels facilitate Ca // influx sion, inhibits apoptosis in vitro, and drives the cell into S phase and activation of endogenous neutral proteases capable of [27, 28] . It is therefore possible that sublytic C5b-9 insertion cleaving structural myelin proteins, including P0 and MBP, to into myelinating Schwann cells enhances myelin divestment cause splitting of myelin lamellae and vesiculation [21] .
by inducing expression of the premyelinating phenotype and Increasing evidence suggests that one of the earliest detectstimulating cell division, thereby ultimately contributing to reable effectors in the peripheral nerve in GBS is the transient pair and remyelination. Terminal activation products of the deposition of C3d and C5b-9 on the Schwann cell internode complement cascade may also increase interaction between [22] or at the nodes of Ranvier. This can occur as early as 4
Schwann cells and macrophages through up-regulation of days after the development of neurologic symptoms, prior to Schwann cell intercellular adhesion molecule, a ligand of CR3 / infiltration of mononuclear cells. Vesiculation of the superficial on macrophages. myelin lamellae is associated with C5b-9 deposition on the C. jejuni is one of a series of infectious organisms implicated Schwann cell internodes followed by association with macroin triggering GBS in some patients. It is proposed that through phages containing phagocytosed myelin membrane expressing antigenic mimicry, the immune response against the infectious C5b-9. Despite the evidence of high levels of circulating comagents induces endoneurial inflammation, some of which is plement-fixing antibody capable of binding Schwann cells in directed toward the Schwann cell. This multipotential glial cell, GBS patients [23] and immunohistologic evidence of C5b-9 vital for the normal physiologic function of peripheral nerve, insertion in Schwann cell plasma membrane in GBS patients, is hypothetically capable of contributing to the inflammatory Schwann cells are resistant to complement-mediated attack process through production of cytokines, acute-phase reactants, [24] . This in part reflects the expression of molecules that and growth factors. Much of this work has been done in in prevent or enhance degradation of complement-activation vitro systems. The extent to which such factors contribute to products [24, 25] . the in vivo process remains a subject of investigation. Complement cascade activation on target membranes is down-regulated by membrane proteins. CR1 (CD35), as a cofactor for factor I, enhances C4b and C3b breakdown. Decay-
